Core Laboratories N.V. (CLB) — Financial statements
Income statement, balance sheet, and cash flow for Core Laboratories N.V. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 527↑0.5% | 524↑2.8% | 510↑4.1% | 490↑4.1% | 470 | |
| Cost of Revenue | 432↓0.7% | 435↑4.7% | 416↑1.2% | 411↑6.3% | 386 | |
| Gross Profit | 94↑6.7% | 88↓6.0% | 94↑19.2% | 79↓5.9% | 84 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 44↑14.6% | 39↓4.1% | 40↑5.6% | 38↓13.7% | 44 | |
| Selling & Marketing Expenses | 0.00 | 0.00↑100.0% | -1 | 0.00 | 0.00 | |
| SG&A Expenses | 44↑14.6% | 39↓0.8% | 39↑2.0% | 38↓13.7% | 44 | |
| Other Expenses | -0.43↑95.1% | -9↓1803.9% | 0.52↑171.3% | -0.72↑87.1% | -6 | |
| Operating Expenses | 44↑46.9% | 30↓24.3% | 39↑5.4% | 37↓3.1% | 39 | |
| Total Costs & Expenses | 476↑2.3% | 465↑2.2% | 455↑1.5% | 448↑5.5% | 425 | |
| Operating Results | ||||||
| Operating Income | 50↓13.8% | 59↑7.2% | 55↑31.6% | 42↓8.3% | 45 | |
| Depreciation & Amortization | 15↓2.0% | 15↓5.3% | 16↓8.0% | 17↓7.3% | 19 | |
| EBITDA | 71↓2.9% | 73↑4.0% | 70↑20.0% | 59↓8.0% | 64 | |
| EBIT | 56↓3.6% | 59↑7.2% | 55↑31.6% | 42↓8.3% | 45 | |
| Interest & Other Income | ||||||
| Net Interest Income | -11↑14.5% | -12↑7.9% | -13↓16.1% | -12↓26.4% | -9 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 11↓14.5% | 12↓7.9% | 13↑16.1% | 12↑26.4% | 9 | |
| Non-Operating Income | -6 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | -5↑62.9% | -12↑7.9% | -13↓16.1% | -12↓26.4% | -9 | |
| Income Before Tax | 46↓0.6% | 46↑12.1% | 41↑37.6% | 30↓17.0% | 36 | |
| Income Tax Expense | 16↑10.5% | 14↑235.3% | 4↓59.4% | 10↓35.2% | 16 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 30↓5.5% | 32↓13.2% | 37↑88.3% | 20↓2.5% | 20 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 30↓5.5% | 31↓14.4% | 37↑88.5% | 19↓1.4% | 20 | |
| Bottom-Line Net Income | 30↓5.5% | 31↓14.4% | 37↑88.5% | 19↓1.4% | 20 | |
| EPS (Basic) | 0.68↑1.5% | 0.67↓15.2% | 0.79↑88.1% | 0.42↓2.3% | 0.43 | |
| EPS (Diluted) | 0.68↑3.0% | 0.66↓14.3% | 0.77↑83.3% | 0.42↑0.0% | 0.42 | |
| Weighted Average Shares | 47↓0.8% | 47↑0.5% | 47↑0.8% | 46↑0.7% | 46 | |
| Weighted Average Diluted Shares | 47↓2.5% | 48↑0.3% | 48↑1.5% | 47↑0.3% | 47 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.